Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by cheng xiang
Transferrin Receptor-Targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Related publications
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinicopathological Features Predict Outcomes in Patients With Radioiodine‐Refractory Differentiated Thyroid Cancer Treated With Sorafenib: A Real‐World Study
Oncologist
Cancer Research
Medicine
Oncology
Clinical Cases of the Efficacy of Therapy Multikinase Inhibitors of Metastatic Radioid-Refractory Differentiated Thyroid Cancer
Endocrine Surgery
Transferrin Receptor Targeted Lipopolyplexes for Delivery of Antisense Oligonucleotide G3139 in a Murine K562 Xenograft Model
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Differentiated Thyroid Cancer
Archives of Surgery
Prescribed Activity of 131 I Therapy in Differentiated Thyroid Cancer
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Potential Role of Sorafenib as Neoadjuvant Therapy in Unresectable Papillary Thyroid Cancer
Archives of endocrinology and metabolism
Endocrinology
Metabolism
Diabetes
Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Lymph Node Dissection for Differentiated Thyroid Cancer
Molecular Imaging and Radionuclide Therapy
Nuclear Medicine
Radiology
Imaging
